Companies /Healthcare

Viemed Healthcare Inc

NASDAQ: VMD Medical Devices
$9.10
▼ $0.08 (−0.82%) today
Markets open · 1:55pm ET

VMD at a Glance

Valuation
Market cap
$347.5M
P/E ratio
24.1
Profitability
Revenue (TTM)
$310.4M
Profit margin
5.0%
EPS (TTM)
$0.38
Price
52-week range
$6 – $13
Street target
$12.00

Headquartered in Lafayette, LA Fiscal year ends December NASDAQ: VMD viemed.com

About Viemed Healthcare

Viemed Healthcare, Inc. (NASDAQ: VMD) provides home medical equipment and post-acute, technology-enabled home-based healthcare services in the United States. It serves over 223,000 patients across all 50 states.

The business was built around complex respiratory care, chiefly non-invasive and invasive ventilation for patients with COPD and chronic respiratory failure. Its service model includes 24/7 respiratory therapist support and remote patient monitoring. Ventilation revenue is rental-based, with average monthly reimbursement of about $1,050 and an average length of stay of about 17 months.

The company has broadened into adjacent lines:
- Sleep, including PAP therapy and a sleep resupply program
- Oxygen, using tankless portable concentrators
- Airway clearance, including nebulizers, cough assists and percussion vests
- Women's health, including insurance-covered breast pumps, maternal supplies and postpartum compression garments
- Healthcare staffing for hospitals and agencies

This expansion was driven partly by acquisitions: HMP in 2023, a hospital joint venture with EAMC in 2024, and Lehan's Medical Equipment in July 2025, which added women's health and a Chicago-market platform.

Viemed runs a lean, storefront-free model with a mobile clinical workforce. It focuses on technology-enabled products rather than heavy-logistics durable medical equipment. Revenue is reported as ventilator rentals, other home medical equipment rentals, equipment and supply sales, and service revenues.

In Q3 2026 the payor mix was:
- Medicare 34%
- Commercial 24%
- Medicare Advantage 21%
- Medicaid/MCO 9%
- Other 12% Updated

Latest Activity

VMDViemed Healthcare
Q3 2026
EPS
$0.11
est $0.12-10.8%
Revenue
$81M
est $81M-0.1%

Adjusted EBITDA margin widened to 21.1% from 17.6% a year ago as earlier-2026 spending converted to operating leverage, even with both lines missing estimates. Management raised the floor of full-year revenue guidance to $316 million and authorized a buyback covering up to 5% of shares.

Quarterly EPS — reported vs estimate

VMD Coverage

Frequently Asked Questions

What does Viemed Healthcare do?

Viemed Healthcare, Inc. (NASDAQ: VMD) provides home medical equipment and post-acute, technology-enabled home-based healthcare services in the United States. It serves over 223,000 patients across all 50 states.

What is the VMD stock price target?

The Wall Street consensus 12-month price target for VMD is $12.00.